AAV Capsid Stability via MAAP Translation Inactivation
Find Innovative SolutionsGenerate Solutions
Solution Overview
Problem
Current methods for producing adeno-associated virus (AAV) for gene therapy face challenges in stability and yield, particularly due to rapid degradation of certain serotypes like AAV2 and AAV8, which limits their availability and effectiveness in large-scale manufacturing.
Innovation Solution
Introducing mutations that inactivate the membrane-associated accessory protein (MAAP) mRNA translation-initiation codon or introduce stop codons to reduce MAAP expression, while maintaining VP1 expression, thereby enhancing viral production, stability, and capsid integrity.
Engineering Contradictions & Design Principles
Engineering Contradiction Analysis
1Productivity
If producer cells are cultured for at least 72 hours to increase virus production, then viral yield is improved, but capsid degradation occurs reducing final infective virus yield
Solution Approach 1:
The invention modifies the capsid protein composition by adjusting the VP1:VP2:VP3 ratio to enhance capsid stability during extended culture periods, allowing producer cells to be maintained for at least 72 hours without significant degradation, thereby resolving the contradiction between maximizing viral yield and maintaining capsid integrity
Solution Approach 2:
The invention performs preliminary optimization of capsid protein expression ratios before virus production, pre-configuring the capsid structure to be more resistant to degradation, which enables extended culture periods to proceed without compromising capsid stability and allows maximum viral yield to be achieved
2Reliability
If early harvesting is performed at 24 hours to reduce capsid degradation, then capsid stability is improved, but viral replication is prematurely halted reducing overall virus production
Solution Approach 1:
The invention changes the capsid protein composition parameters to create a more stable capsid structure that resists degradation over time, allowing the virus to maintain integrity during extended culture periods and enabling harvesting at later time points to achieve both high stability and high yield
3Adaptability or versatility
If MAAP expression is maintained at wild-type levels, then natural viral function is preserved, but capsid degradation increases reducing production efficiency
Solution Approach 1:
The invention applies local quality modification by specifically adjusting the expression levels of certain capsid proteins (VP1:VP2:VP3 ratio) while maintaining others, creating a localized optimization that enhances capsid stability and production efficiency without compromising the overall viral function and transduction capability
Data Source
AI summary
“MAAP” is a naturally-occurring, newly-discovered about 13 KDa adeno-associated vims protein. It is not homologous to known proteins. When AAV producer cells are cultured for more than 24 hours, we found that inactivating translation of the full-length MAAP improves the productivity of the transfected producer cells. The resulting AAV viruses are also of better quality and more stable. Our findings thus provide a way to improve the industrial manufacture of recombinant adeno-associated virus gene therapy vectors.